Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production
- PMID: 32130898
- DOI: 10.1016/j.celrep.2020.02.013
Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production
Abstract
Secondary bacterial infections often complicate viral respiratory infections. We hypothesize that perturbation of the gut microbiota during influenza A virus (IAV) infection might favor respiratory bacterial superinfection. Sublethal infection with influenza transiently alters the composition and fermentative activity of the gut microbiota in mice. These changes are attributed in part to reduced food consumption. Fecal transfer experiments demonstrate that the IAV-conditioned microbiota compromises lung defenses against pneumococcal infection. In mechanistic terms, reduced production of the predominant short-chain fatty acid (SCFA) acetate affects the bactericidal activity of alveolar macrophages. Following treatment with acetate, mice colonized with the IAV-conditioned microbiota display reduced bacterial loads. In the context of influenza infection, acetate supplementation reduces, in a free fatty acid receptor 2 (FFAR2)-dependent manner, local and systemic bacterial loads. This translates into reduced lung pathology and improved survival rates of double-infected mice. Lastly, pharmacological activation of the SCFA receptor FFAR2 during influenza reduces bacterial superinfection.
Keywords: acetate; bacterial superinfection; food restriction; free fatty acid receptor 2; gut microbiota; influenza A virus; macrophages; microbial dysbiosis; short-chain fatty acid.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests A.B., V.S., M.M.T., L.P.T., F.T., and A.T.V. are inventors of patent WO2019149727, “Use of short chain fatty acids for the treatment of bacterial superinfections post-influenza.” V.S., T.U., and F.T. are inventors of patent EP19188615.9, “Use of free fatty acid receptor 2 agonists for the treatment of bacterial superinfections post-influenza.”
Similar articles
-
High-fat diet impairs microbial metabolite production and aggravates influenza A infection.Cell Commun Signal. 2025 Jul 31;23(1):359. doi: 10.1186/s12964-025-02367-w. Cell Commun Signal. 2025. PMID: 40745568 Free PMC article.
-
Gut microbiota-derived acetate attenuates lung injury induced by influenza infection via protecting airway tight junctions.J Transl Med. 2024 Jun 15;22(1):570. doi: 10.1186/s12967-024-05376-4. J Transl Med. 2024. PMID: 38879538 Free PMC article.
-
Influenza Virus Infection Impairs the Gut's Barrier Properties and Favors Secondary Enteric Bacterial Infection through Reduced Production of Short-Chain Fatty Acids.Infect Immun. 2021 Aug 16;89(9):e0073420. doi: 10.1128/IAI.00734-20. Epub 2021 Aug 16. Infect Immun. 2021. PMID: 33820816 Free PMC article.
-
Emerging pathogenic links between microbiota and the gut-lung axis.Nat Rev Microbiol. 2017 Jan;15(1):55-63. doi: 10.1038/nrmicro.2016.142. Epub 2016 Oct 3. Nat Rev Microbiol. 2017. PMID: 27694885 Review.
-
Antibiotic-induced dysbiosis effects on the murine gastrointestinal tract and their systemic repercussions.Life Sci. 2018 Aug 15;207:480-491. doi: 10.1016/j.lfs.2018.06.030. Epub 2018 Jul 4. Life Sci. 2018. PMID: 30056862 Review.
Cited by
-
Is the oral microbiome a source to enhance mucosal immunity against infectious diseases?NPJ Vaccines. 2021 Jun 2;6(1):80. doi: 10.1038/s41541-021-00341-4. NPJ Vaccines. 2021. PMID: 34078913 Free PMC article. Review.
-
Control of lymphocyte functions by gut microbiota-derived short-chain fatty acids.Cell Mol Immunol. 2021 May;18(5):1161-1171. doi: 10.1038/s41423-020-00625-0. Epub 2021 Apr 13. Cell Mol Immunol. 2021. PMID: 33850311 Free PMC article. Review.
-
Research progress on the mechanism of traditional Chinese medicine regulating intestinal microbiota to combat influenza a virus infection.Virol J. 2023 Nov 13;20(1):260. doi: 10.1186/s12985-023-02228-3. Virol J. 2023. PMID: 37957630 Free PMC article. Review.
-
The past, present and future of RNA respiratory viruses: influenza and coronaviruses.Pathog Dis. 2020 Oct 7;78(7):ftaa046. doi: 10.1093/femspd/ftaa046. Pathog Dis. 2020. PMID: 32860686 Free PMC article. Review.
-
Microbiota as a potentially-modifiable factor influencing COVID-19.Curr Opin Virol. 2021 Aug;49:21-26. doi: 10.1016/j.coviro.2021.04.005. Epub 2021 Apr 21. Curr Opin Virol. 2021. PMID: 34000641 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases